WallStreetZenWallStreetZen

NASDAQ: DBTX
Decibel Therapeutics Inc Earnings & Revenue

Open Broker Account

DBTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$60.4M
Current Profit Margin
0%

DBTX Return on Equity

Current Company
-45.1%
Current Industry
4.1%
Current Market
25.7%
DBTX's Return on Equity (-45.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DBTX announces earnings.

DBTX Return on Assets

Current Company
-34.4%
Current Industry
3.4%
DBTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DBTX Return on Capital Employed

Current Company
-43.18%
Current Industry
9.7%

DBTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DBTX$0.00-$56.21M-$60.36MN/AN/A
CADL$0.00-$18.94M-$19.59MN/AN/A
BIOR$828.00k-$144.70M-$155.94M-87.85%N/A
IFRX$0.00-$38.34M-$39.04MN/AN/A
IPA$14.75M-$13.53M-$17.32M+15.24%N/A

DBTX earnings dates

Next earnings date
Nov 8, 2022

Decibel Therapeutics Earnings & Revenue FAQ

What were DBTX's earnings last quarter?

On Invalid Date, Decibel Therapeutics (NASDAQ: DBTX) reported Q2 2022 earnings per share (EPS) of -$0.68, up 44.68% year over year. Total Decibel Therapeutics earnings for the quarter were -$17.05 million. In the same quarter last year, Decibel Therapeutics's earnings per share (EPS) was -$0.47.

If you're new to stock investing, here's how to buy Decibel Therapeutics stock.

What was DBTX's earnings growth in the past year?

As of Q3 2022, Decibel Therapeutics's earnings has grown year over year. Decibel Therapeutics's earnings in the past year totalled -$60.36 million.

What is DBTX's earnings date?

Decibel Therapeutics's earnings date is Invalid Date. Add DBTX to your watchlist to be reminded of DBTX's next earnings announcement.

What was DBTX's revenue last quarter?

On Invalid Date, Decibel Therapeutics (NASDAQ: DBTX) reported Q2 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Decibel Therapeutics's revenue was $0.00.

What was DBTX's revenue growth in the past year?

As of Q3 2022, Decibel Therapeutics's revenue has grown null year over year. Decibel Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.